在急性不补偿性心力衰竭患者中,左心室相对壁厚是5年死亡率的预测因素吗?
Sefa Tatar1, Hasan Kan1, Yunus Emre Yavuz1
1Department of Cardiology, Necmettin Erbakan University, Meram Faculty of Medicine, Meram, Konya, Turkey.
JRSM cardiovascular disease
|February 9, 2026
概括
相对壁厚 (RWT) 不能可靠地预测心力衰竭 (HF) 患者的5年死亡率. 年龄是一个更强的预测因素,RWT应该与其他临床因素一起考虑,以更好地管理HF.
科学领域:
- 心脏病学 心脏病学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
- 心脏衰竭研究研究
背景情况:
- 心力衰竭 (HF) 是一个日益增长的全球健康挑战,特别是在老年人群中.
- 相对壁厚 (RWT) 是对心脏几何重塑的回声心脏学测量,具有潜在的预后价值.
- 评估RWT对HF患者长期死亡率的预测能力至关重要.
研究的目的:
- 评估相对壁厚 (RWT) 的预后能力,以预测心力衰竭患者的5年死亡率.
- 确定RWT测量是否可以在5年时间范围内识别高死亡风险的患者.
- 在预测HF死亡率方面,将RWT与其他临床和心声学参数进行比较.
主要方法:
- 对232名急性不补偿性心力衰竭患者的回顾性分析.
- 使用心声回声数据计算RWT.
- 基于5年生存状况的患者分层和人口,临床和心声学参数的比较.
主要成果:
- 5年后,133名患者 (57%) 死亡. 死亡率与年龄较大,慢性功能衰竭,心房动和心肌回有关.
- 较高的缩性肺动脉压 (sPAP) 与死亡率有关,但在回归分析中没有统计学意义.
- 幸存者和非幸存者之间的相对壁厚 (RWT) 并没有显著差异 (p=0.225),曲线下的面积为0.50,表明预测能力差.
结论:
- 相对壁厚 (RWT) 表明预测晚期心力衰竭 (HF) 患者5年死亡率的能力有限.
- 患者年龄被确定为该队列中死亡率最强的独立预测因素.
- 应将RWT与其他临床和实验室参数集成为全面的HF管理,而不是单独使用.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
656
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.9K
相关概念视频
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V
510
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
510
Heart Failure II: Pathophysiology
987
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
987
Pathophysiology of Heart Failure
3.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K
Heart Failure I: Introduction
937
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
937
